COMMUNIQUÉS West-GlobeNewswire

Standard Dental Labs Inc. Files 2025 Annual Report and Audited Financial Statements 2025 Following Transformational Year and Recent Acquisition Positioning Company for Potential, Significant Revenue Growth
09/04/2026
ORLANDO, Fla., April 09, 2026 (GLOBE NEWSWIRE) -- Standard Dental Labs Inc. (OTC: TUTH) (“Standard Dental Labs” and the “Company”) today announced the filing of its 2025 Annual Report on Form 1-K and its audited [...]
Extendicare Announces $450 Million Inaugural Offering of Investment Grade Senior Unsecured Notes
09/04/2026
Not for distribution to U.S. news wire services or dissemination in the United States. MARKHAM, Ontario, April 09, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“ Extendicare ” or the “ Company ”) (TSX: EXE) announced [...]
LB Pharmaceuticals Announces Presentation at 25th Annual Needham Virtual Healthcare Conference
09/04/2026
NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar [...]
Sobi Receives Health Canada Approval for EMPAVELI® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN
09/04/2026
EMPAVELI ® (pegcetacoplan) is the first approved treatment for C3G or primary IC-MPGN for patients 12 years and older in Canada Approval supported by Phase 3 52-week VALIANT study demonstrated reduced proteinuria, [...]
Verrica Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting Potential Abscopal Effect of VP-315 for the Treatment of Basal Cell Carcinoma at the Upcoming 2026 Society for Investigative Dermatology Annual Meeting
09/04/2026
WEST CHESTER, Pa., April 09, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a therapeutics company developing and commercializing medications for the treatment of dermatological [...]
Sobi reçoit l’autorisation par Santé Canada pour EMPAVELIMD (pegcétacoplan) dans le traitement de la GC3 et de la GNMP-CI primitive.
09/04/2026
EMPAVELI MD (pegcétacoplan) est le premier traitement autorisé dans le traitement des patients adultes et pédiatriques de 12 ans et plus atteints de glomérulopathie à dépôts de C3 (GC3) ou de glomérulonéphrite [...]
PROCEPT BioRobotics® to Report First Quarter 2026 Financial Results on April 29, 2026
09/04/2026
SAN JOSE, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics ® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions [...]
Certara to Report First Quarter 2026 Financial Results on May 11th, 2026
09/04/2026
RADNOR, Pa., April 09, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the first quarter of 2026 [...]
Dental Care of Stamford Challenges the Myths Holding Stamford Residents Back from the Smile They Want
09/04/2026
A new patient resource from a leading cosmetic dentist in Stamford, CT addresses the fears, misconceptions, and outdated beliefs that prevent adults from exploring modern cosmetic dentistry options. STAMFORD, CT, April [...]
Medical Centre in Blacktown goes Bulk Billed
09/04/2026
Kildare Road Medical Centre Strengthens Commitment to Accessible Healthcare in Blacktown Sydney, NEW SOUTH WALES, April 09, 2026 (GLOBE NEWSWIRE) -- Kildare Road Medical Centre has reaffirmed its commitment to [...]
ClinNEXUS to Participate as Featured Speaker in Suncoast Ventures Gateway Conference on Healthcare Innovation
09/04/2026
LOS ANGELES, April 09, 2026 (GLOBE NEWSWIRE) -- ClinNEXUS, (or the “Company”) a data-driven healthcare company that’s redefining care coordination by uniting clinical, social, and behavioral support to improve lives and [...]
Emergent BioSolutions Partners with British Columbia to Supply NARCAN® Nasal Spray for the Launch of the Expanded BC Take Home Naloxone Program
09/04/2026
WINNIPEG, Manitoba, April 09, 2026 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (NYSE: EBS) announced that it has partnered with the B.C. Provincial Health Services Authority (PHSA) to supply NARCAN ® Nasal Spray for [...]
Cardiff Oncology Announces Key Leadership Appointments to Strengthen Executive Team for Next Phase of Growth
09/04/2026
Board member and Interim CEO Mani Mohindru, PhD, named President and Chief Executive Officer Appoints industry veterans Josh Muntner as Chief Financial Officer and Ajay Aggarwal, MD, MBA, as Chief Operating Officer SAN [...]
Solana Company (NASDAQ: HSDT) Appoints Madelene Gani as Chief Operating Officer and Deputy CFO to Lead Next Phase of Growth
09/04/2026
A veteran architect of Gemini’s Asia Pacific expansion, Ms. Gani joins to lead institutional buildout as Solana Company executes on its strategy to drive yield expansion, enhance revenue generation, advance business [...]
SOUND Behavioral Health Celebrates 60 Years of Service and Leadership in King County
09/04/2026
SEATTLE, April 09, 2026 (GLOBE NEWSWIRE) -- This year, SOUND Behavioral Health celebrates a remarkable milestone: 60 years of serving the people of King County with transformative mental health care, while standing with [...]
Erratum: Correction of press release published on April 7th, 2026
09/04/2026
The press release published on April 7 th , related to the acquisition of own shares, contained the following errors: In the third paragraph, the number of repurchased shares shall read “32,000” instead of “16,000”; In [...]
Erratum: Correction du communiqué de presse publié le 7 avril 2026
09/04/2026
Le communiqué de presse publié le 7 avril 2026, relatif à l’acquisition d’actions propres, contenait les erreurs suivantes : Au troisième paragraphe, le nombre d’actions rachetées doit être “32.000 ” au lieu de “16.000 [...]
USA Today Names Aledade a 2026 Top Workplace for People-First Culture
09/04/2026
National award honors Aledade’s commitment to employee engagement and its mission-driven approach to advancing value-based care BETHESDA, Md., April 09, 2026 (GLOBE NEWSWIRE) -- Aledade , a physician-led, national [...]
Cynet Named Leader and Outperformer in 2026 GigaOm Radar for Extended Detection and Response (XDR)
09/04/2026
BOSTON, April 09, 2026 (GLOBE NEWSWIRE) -- Cynet, the unified, AI-powered cybersecurity platform empowering organizations to focus on what matters most, has been named a Leader and Outperformer in the 2026 GigaOm Radar [...]

Pages